Jeong H - Search Results

1

Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study.

Oh CR, Jeong H, Kim W, Lee JS, Song SY, Song JS, Cho KJ, Chung HW, Lee MH, Hong JY, Lee J, Kim JE, Ahn JH. Oh CR, et al. Among authors: jeong h. Int J Clin Oncol. 2024 Jun;29(6):853-861. doi: 10.1007/s10147-024-02506-2. Epub 2024 Mar 25. Int J Clin Oncol. 2024. PMID: 38526622

2

The Role and Clinical Effectiveness of Multiline Chemotherapy in Advanced Desmoplastic Small Round Cell Tumor.

Jeong H, Hong YS, Kim YH, Kim CW, Song SY, Song JS, Cho KJ, Kim JE, Ahn JH. Jeong H, et al. Clin Med Insights Oncol. 2021 Feb 17;15:1179554920987107. doi: 10.1177/1179554920987107. eCollection 2021. Clin Med Insights Oncol. 2021. PMID: 33642889 Free PMC article.

3

A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer.

Jeong H, Hong YS, Kim JE, Lim HS, Ahn JB, Shin SJ, Park YS, Kim ST, Han SW, Kim TY, Kim TW. Jeong H, et al. Invest New Drugs. 2021 Oct;39(5):1335-1347. doi: 10.1007/s10637-021-01110-9. Epub 2021 Apr 7. Invest New Drugs. 2021. PMID: 33829355 Clinical Trial.

4

Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor-positive, HER2-negative metastatic breast cancer.

Jeong H, Jeong JH, Kim JE, Ahn JH, Jung KH, Koh SJ, Cheon J, Sohn J, Kim GM, Lee KS, Sim SH, Park IH, Kim SB. Jeong H, et al. Among authors: jeong jh. Int J Cancer. 2021 Apr 27. doi: 10.1002/ijc.33613. Online ahead of print. Int J Cancer. 2021. PMID: 33905134

5

Comparison of the Effectiveness and Clinical Outcome of Everolimus Followed by CDK4/6 Inhibitors with the Opposite Treatment Sequence in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer.

Jeong H, Jeong JH, Kim JE, Ahn JH, Jung KH, Kim SB. Jeong H, et al. Among authors: jeong jh. Cancer Res Treat. 2022 Apr;54(2):469-477. doi: 10.4143/crt.2021.205. Epub 2021 Jun 23. Cancer Res Treat. 2022. PMID: 34176251 Free PMC article.

6

Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea-A Sarcoma-Specific, Institutional Registry-Based Analysis.

Jeong H, Im HS, Kim W, Lee JS, Song SY, Song JS, Cho KJ, Chung HW, Lee MH, Kim JE, Ahn JH. Jeong H, et al. Cancer Manag Res. 2021 Nov 24;13:8795-8802. doi: 10.2147/CMAR.S337606. eCollection 2021. Cancer Manag Res. 2021. PMID: 34853534 Free PMC article.

7

Clinicogenomic Characteristics and Treatment of Young-Onset Colorectal Cancer Patients Treated With Palliative Therapy in Real-World Practice.

Jeong H, Lee E, Kim D, Kim J, Kim SY, Hong YS, Kim TW, Kim JE. Jeong H, et al. Cancer Control. 2022 Jan-Dec;29:10732748221096842. doi: 10.1177/10732748221096842. Cancer Control. 2022. PMID: 35475677 Free PMC article.

8

Modified Stage Grouping of Diffuse Large B-Cell Lymphoma Involving the Same Side of the Diaphragm in the Rituximab Era.

Jeong H, Cho H, Hong JY, Lee DH, Kim S, Lee K, Kang EH, Park JS, Ryu JS, Huh J, Suh C. Jeong H, et al. Front Oncol. 2022 May 27;12:888925. doi: 10.3389/fonc.2022.888925. eCollection 2022. Front Oncol. 2022. PMID: 35712469 Free PMC article.

9

Central nervous systemic efficacy of immune checkpoint inhibitors and concordance between intra/extracranial response in non-small cell lung cancer patients with brain metastasis.

Kang S, Jeong H, Park JE, Kim HS, Kim YH, Lee DH, Kim SW, Lee JC, Choi CM, Yoon S. Kang S, et al. Among authors: jeong h. J Cancer Res Clin Oncol. 2023 Jul;149(8):4523-4532. doi: 10.1007/s00432-022-04251-3. Epub 2022 Sep 22. J Cancer Res Clin Oncol. 2023. PMID: 36136277

10

Pathological complete response, long-term outcomes, and recurrence patterns in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy.

Kang S, Lee SH, Lee HJ, Jeong H, Jeong JH, Kim JE, Ahn JH, Jung KH, Gong G, Kim HH, Lee S, Lee J, Kim SB. Kang S, et al. Among authors: jeong h, jeong jh. Eur J Cancer. 2022 Nov;176:30-40. doi: 10.1016/j.ejca.2022.08.031. Epub 2022 Sep 29. Eur J Cancer. 2022. PMID: 36183652 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,912 results

Search Page

Filters